OPKO Health, Inc. reported $588M of revenue over the trailing twelve months, −11% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $588M (to Q2 2026). Net income: −$73M, trailing twelve months to Q2 2026. Free cash flow: −$134M, trailing twelve months to Q2 2026. Operating margin: −9.9%, trailing twelve months to Q2 2026.

OPKOPKO Health, Inc.

Healthcare

$1.38-4.8% 1Y

$1.38

$1.1052 weeks$1.73

OPK as reported

OPKO Health, Inc. reported $588M of revenue over the trailing twelve months, −11% on the year before. 11 reported series are charted on this page, each one as filed.

$588M

Revenue, trailing twelve months · to Q2 2026 · −11% against the twelve months before

Net income: −$73M
Net income · −59% year on year · trailing twelve months to Q2 2026
Free cash flow: −$134M
Free cash flow · −48% year on year · trailing twelve months to Q2 2026
Operating margin: −9.9%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for OPK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$588M	−11%	Q2 2026
Net income	−$73M	−59%	Q2 2026
EPS	−$0.09	−64%	Q2 2026
Gross margin	40%	n/a	Q2 2026
Operating margin	−9.9%	n/a	Q2 2026
Net margin	−14%	n/a	Q2 2026
ROE	−14%	n/a	Q2 2026
ROA	−9.0%	n/a	Q2 2026
ROIC	−8.4%	n/a	Q2 2026
Free cash flow	−$134M	−48%	Q2 2026
P/E	42.9	n/a	Q3 2021 · 19 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.